Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory Yh Lip

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Expert Review of Cardiovascular Therapy|March 22, 2014
Atrial fibrillation and stroke prevention: brief observations on the last decadeGregory Yh Lip
Expert Review of Cardiovascular Therapy|July 23, 2015
Nonsteroidal anti-inflammatory drugs and bleeding risk in anticoagulated patients with atrial fibrillationGregory Yh Lip
International Journal of Cardiology|March 13, 2017
Geographical differences in thromboembolic and bleeding risks in patients with non-valvular atrial fibrillation: An ancillary analysis from the SPORTIF trialsMarco Proietti, Gregory Yh Lip
The Cochrane Database of Systematic Reviews|September 16, 2016
Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythmEduard Shantsila, Gregory Yh Lip
BMJ Clinical Evidence|May 19, 2009
Stroke preventionGregory Yh Lip, Lalit Kalra
European Cardiology|December 24, 2021
Palpitations in the Cancer PatientHani Essa, Gregory Yh Lip
European Heart Journal. Acute Cardiovascular Care|January 7, 2017
CHA<sub>2</sub>DS<sub>2</sub>-VASc score risk factors as predictors of stroke after acute coronary syndrome: Can we really be sure there is no atrial fibrillation?Michał Mazurek, Gregory Yh Lip
Alcohol and Alcoholism (Oxford, Oxfordshire)|October 22, 2005
Alcohol and hypertension: an old relationship revisitedJoseph Tomson, Gregory Yh Lip
Expert Opinion on Pharmacotherapy|March 12, 2026
Optimisation of direct-acting oral anticoagulants (DOACs) use for atrial fibrillation (AF) and venous thromboembolism: a practical GuideMichael Griffin, Gregory Yh Lip
Arrhythmia & Electrophysiology Review|July 9, 2020
Mobile Health for Cardiovascular Disease: The New Frontier for AF Management: Observations from the Huawei Heart Study and mAFA-II Randomised TrialYutao Guo, Gregory Yh Lip
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Expert Review of Cardiovascular Therapy|March 22, 2014
Atrial fibrillation and stroke prevention: brief observations on the last decadeGregory Yh Lip
Expert Review of Cardiovascular Therapy|July 23, 2015
Nonsteroidal anti-inflammatory drugs and bleeding risk in anticoagulated patients with atrial fibrillationGregory Yh Lip
International Journal of Cardiology|March 13, 2017
Geographical differences in thromboembolic and bleeding risks in patients with non-valvular atrial fibrillation: An ancillary analysis from the SPORTIF trialsMarco Proietti, Gregory Yh Lip
The Cochrane Database of Systematic Reviews|September 16, 2016
Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythmEduard Shantsila, Gregory Yh Lip
BMJ Clinical Evidence|May 19, 2009
Stroke preventionGregory Yh Lip, Lalit Kalra
European Cardiology|December 24, 2021
Palpitations in the Cancer PatientHani Essa, Gregory Yh Lip
European Heart Journal. Acute Cardiovascular Care|January 7, 2017
CHA<sub>2</sub>DS<sub>2</sub>-VASc score risk factors as predictors of stroke after acute coronary syndrome: Can we really be sure there is no atrial fibrillation?Michał Mazurek, Gregory Yh Lip
Alcohol and Alcoholism (Oxford, Oxfordshire)|October 22, 2005
Alcohol and hypertension: an old relationship revisitedJoseph Tomson, Gregory Yh Lip
Expert Opinion on Pharmacotherapy|March 12, 2026
Optimisation of direct-acting oral anticoagulants (DOACs) use for atrial fibrillation (AF) and venous thromboembolism: a practical GuideMichael Griffin, Gregory Yh Lip
Arrhythmia & Electrophysiology Review|July 9, 2020
Mobile Health for Cardiovascular Disease: The New Frontier for AF Management: Observations from the Huawei Heart Study and mAFA-II Randomised TrialYutao Guo, Gregory Yh Lip
Pageof 14